Study on the relationship between intrapartum group B streptococcus prophylaxis and food allergy in children

Hong Zhang1, Kang Xu1, Zhihui Liu2

  • 1Department of Pediatrics,Taixing People's Hospital, Taizhou, Jiangsu, China.

Frontiers in Pediatrics
|December 19, 2022
PubMed

Insights

Intrapartum antibiotic prophylaxis for group B streptococcus (GBS) in mothers may increase food allergy risk in infants under 18 months. This association was not significant in children up to three years old.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Immunology

Background:

  • Group B Streptococcus (GBS) prophylaxis during labor is common.
  • The long-term effects of GBS prophylaxis on infant health are under investigation.
  • Emerging evidence suggests potential links between early-life antibiotic exposure and immune-related conditions.

Purpose of the Study:

  • To examine the association between intrapartum antibiotic prophylaxis for GBS (GBS-IAP) and the risk of food allergy in Chinese children.
  • To determine if GBS-IAP influences the incidence and timing of food allergy development.
  • To assess these associations at different age points (18 months and 3 years).

Main Methods:

  • A retrospective cohort study involving 2,909 mother-child pairs from Taixing People's Hospital.
  • GBS-IAP defined as intravenous antibiotics (penicillin G, ampicillin, or cefazolin) administered ≥4 hours before delivery.
  • Kaplan-Meier survival analysis, log-rank tests, and Cox proportional hazards models were used to analyze food allergy incidence and risk.

Main Results:

  • Higher cumulative incidence of food allergy in children under 18 months exposed to GBS-IAP (8.1%) compared to controls (4.5%, P=0.005).
  • GBS-IAP was associated with faster food allergy development in children under 18 months (univariate HR: 1.887, P=0.005; multivariate HR: 1.906, P=0.011).
  • No significant differences in food allergy incidence or risk were found in children under three years old.

Conclusions:

  • Intrapartum antibiotic prophylaxis for GBS may elevate the risk of food allergy in infants younger than 18 months.
  • The observed association between GBS-IAP and food allergy diminishes by age three.
  • Further research is warranted to understand the mechanisms and long-term implications of GBS-IAP on child immune development.
Abstract

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.6K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
411
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
387
Cross-reactivity00:42

Cross-reactivity

Overview
31.4K
Allergic Reactions02:06

Allergic Reactions

Overview
28.1K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
924